Gene therapy for hypertension: antisense inhibition with adeno-associated viral vector delivery targeting angiotensin II type 1-receptor messenger ribonucleic acid.
Phillips
M I
MI
University of Florida College of Medicine, Gainesville 32610-0274, USA.
D000804:Angiotensin II; D057911:Angiotensin Receptor Antagonists; D000818:Animals; D000229:Dependovirus / Q000235:genetics; D015316:Genetic Therapy; D005822:Genetic Vectors; D006973:Hypertension / Q000628:therapy*; D016376:Oligonucleotides, Antisense / Q000235:genetics / Q000494:pharmacology*; D012333:RNA, Messenger / Q000037:antagonists & inhibitors; D051381:Rats; D011918:Rats, Inbred SHR; D011945:Receptors, Angiotensin / Q000235:genetics; D012084:Renin-Angiotensin System / Q000187:drug effects / Q000235:genetics
D057911:Angiotensin Receptor Antagonists; D016376:Oligonucleotides, Antisense; D012333:RNA, Messenger; D011945:Receptors, Angiotensin; D000804:Angiotensin II